Supernus Pharms Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for SUPERNUS PHARMS, and what generic alternatives to SUPERNUS PHARMS drugs are available?
SUPERNUS PHARMS has three approved drugs.
There are twenty-five US patents protecting SUPERNUS PHARMS drugs. There is one tentative approval on SUPERNUS PHARMS drugs.
There are forty-four patent family members on SUPERNUS PHARMS drugs in ten countries and one supplementary protection certificate in one country.
Summary for Supernus Pharms
| International Patents: | 44 |
| US Patents: | 25 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
Drugs and US Patents for Supernus Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Supernus Pharms | OXTELLAR XR | oxcarbazepine | TABLET, EXTENDED RELEASE;ORAL | 202810-003 | Oct 19, 2012 | RX | Yes | Yes | 11,166,960 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Supernus Pharms | QELBREE | viloxazine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 211964-003 | Apr 2, 2021 | RX | Yes | Yes | 11,324,753 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Supernus Pharms | TROKENDI XR | topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 201635-004 | Aug 16, 2013 | BC | RX | Yes | Yes | 9,549,940 | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for SUPERNUS PHARMS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Extended-release Capsules | 200 mg | ➤ Subscribe | 2014-04-03 |
| ➤ Subscribe | Extended-release Tablets | 150 mg and 300 mg | ➤ Subscribe | 2013-04-12 |
| ➤ Subscribe | Extended-release Capsules | 25 mg, 50 mg, and 100 mg | ➤ Subscribe | 2014-05-12 |
International Patents for Supernus Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2013079267 | ⤷ Try a Trial |
| World Intellectual Property Organization (WIPO) | 2013119794 | ⤷ Try a Trial |
| Mexico | 2014009528 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Supernus Pharms Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0138441 | SPC/GB95/028 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: TOPIRAMATE; REGISTERED: UK 0242/0301 19950718 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
